Catalina Capital Group LLC Takes $207,000 Position in CME Group Inc. (NASDAQ:CME)

Catalina Capital Group LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CME) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 937 shares of the financial services provider’s stock, valued at approximately $207,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. raised its stake in shares of CME Group by 0.6% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after purchasing an additional 45 shares in the last quarter. CVA Family Office LLC increased its holdings in CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after buying an additional 46 shares during the last quarter. Lester Murray Antman dba SimplyRich raised its position in CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after acquiring an additional 50 shares in the last quarter. Quent Capital LLC lifted its stake in CME Group by 10.2% in the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares during the last quarter. Finally, Grove Bank & Trust grew its position in CME Group by 1.3% in the third quarter. Grove Bank & Trust now owns 4,276 shares of the financial services provider’s stock worth $943,000 after acquiring an additional 55 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Up 0.4 %

CME stock opened at $222.04 on Friday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market cap of $79.96 billion, a PE ratio of 23.35, a price-to-earnings-growth ratio of 5.61 and a beta of 0.55. The business’s 50-day simple moving average is $221.36 and its 200 day simple moving average is $209.75.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. CME Group’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm earned $2.25 EPS. On average, research analysts anticipate that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.07%. CME Group’s dividend payout ratio is 48.37%.

Analysts Set New Price Targets

CME has been the topic of a number of recent research reports. Piper Sandler raised their price target on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a research report on Tuesday, October 8th. Keefe, Bruyette & Woods increased their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Citigroup boosted their target price on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. Finally, Oppenheimer increased their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $222.73.

Insider Transactions at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the sale, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 15,621 shares of company stock valued at $3,441,063. Company insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.